Skip to main content
Top
Published in: Abdominal Radiology 10/2016

01-10-2016 | Perspective

Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology

Authors: Julien S. Wonderlick, Robert D’Agostino

Published in: Abdominal Radiology | Issue 10/2016

Login to get access

Abstract

Clostridium difficile is a well-established cause of nosocomial gastrointestinal disease. Although antibiotics remain an effective first-line treatment for C. difficile colitis (CDC), relapse and recurrence are common. FMT has emerged as one of the safest and most effective known therapies available for recurrent or refractory CDC, which is likely due to restoration of the protective microbiotic barrier of the gastrointestinal tract. FMT varies greatly across institutions by route of delivery, dose, and protocol. We present our experience with FMT via fluoroscopic-guided nasojejunal catheter placement. The discussion will include indications and contraindications, protocol, and procedural technique, and include a case presentation incorporating original CT and fluoroscopic images. Specifically, we will address the advantages and disadvantages of image-guided FMT via the upper GI tract with respect to nasogastric-, colonoscopic-, and enema-based delivery. The efficacy of FMT for the treatment of C. difficile has been widely demonstrated in several prospective and case studies. We feel that nasojejunal FMT is an underutilized radiologic procedure which can benefit selected patients, particularly given the advantages in risk profile, cost, convenience, and lack of routine sedation.
Literature
1.
go back to reference Riddle DJ, Dubberke ER (2009) Trends in Clostridium difficile disease: epidemiology and intervention. Infect Med. 26(7):211–220 Riddle DJ, Dubberke ER (2009) Trends in Clostridium difficile disease: epidemiology and intervention. Infect Med. 26(7):211–220
2.
go back to reference Barbut F, Richard A, Hamadi K, et al. (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38(6):2386–2388PubMedPubMedCentral Barbut F, Richard A, Hamadi K, et al. (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38(6):2386–2388PubMedPubMedCentral
3.
go back to reference Loo VG, Bourgault AM, Poirier L, et al. (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365(18):1693–1703CrossRefPubMed Loo VG, Bourgault AM, Poirier L, et al. (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365(18):1693–1703CrossRefPubMed
4.
go back to reference Britton RA, Young VB (2014) Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146(6):1547–1553CrossRefPubMedPubMedCentral Britton RA, Young VB (2014) Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146(6):1547–1553CrossRefPubMedPubMedCentral
5.
go back to reference van Nood E, Vrieze A, Nieuwdorp M, et al. (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407–415CrossRefPubMed van Nood E, Vrieze A, Nieuwdorp M, et al. (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407–415CrossRefPubMed
7.
go back to reference Kassam Z, Lee CH, Yuan Y, Hunt RH (2013) Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108(4):500–508CrossRefPubMed Kassam Z, Lee CH, Yuan Y, Hunt RH (2013) Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108(4):500–508CrossRefPubMed
8.
go back to reference Drekonja D, Reich J, Gezahegn S, et al. (2015) Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med 162(9):630–638CrossRefPubMed Drekonja D, Reich J, Gezahegn S, et al. (2015) Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med 162(9):630–638CrossRefPubMed
9.
go back to reference Costello SP, Chung A, Andrews JM, Fraser RJ (2015) Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. Am J Gastroenterol 110(5):775–777CrossRefPubMed Costello SP, Chung A, Andrews JM, Fraser RJ (2015) Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. Am J Gastroenterol 110(5):775–777CrossRefPubMed
10.
go back to reference Seril DN, Ashburn JH, Lian L, Shen B (2014) Risk factors and management of refractory or recurrent Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis 20(12):2226–2233CrossRefPubMed Seril DN, Ashburn JH, Lian L, Shen B (2014) Risk factors and management of refractory or recurrent Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis 20(12):2226–2233CrossRefPubMed
11.
go back to reference Moayyedi P, Surette MG, Kim PT, et al. (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149(1):102–109CrossRefPubMed Moayyedi P, Surette MG, Kim PT, et al. (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149(1):102–109CrossRefPubMed
Metadata
Title
Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology
Authors
Julien S. Wonderlick
Robert D’Agostino
Publication date
01-10-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0801-0

Other articles of this Issue 10/2016

Abdominal Radiology 10/2016 Go to the issue